News
-
.2010
Third Quarter 2010
Please see enclosed report
-
.2010
Regarding speculations in Swedish media
(Oslo, Norway, 4 November 2010) At 13:38 today the Oslo Stock Exchange suspended trading in “BIONOR” based on price developments stemming from speculations in Swedish media regarding the future of Vacc-4x.
-
.2010
Henrik Lund MD Ph.D Named as New CEO
Henrik Lund MD Ph.D, Former Global VP in Clinical Development at Astra Zeneca, Named New CEO of Bionor Pharma ASA.
-
.2010
Second Quarter and Half Year Report
Please see enclosed report
-
.2010
Changed Financial Calendar 2010
-
.2010
Mandatory notification of trade
The Board Member of Bionor Pharma ASA, Thomas Falck, has today purchased 75,000 BIONOR shares..
-
.2010
Mandatory notification of trade
The Chairman of the Board of Bionor Pharma ASA, Wenche Rolfsen, has today purchased 68,500 BIONOR shares
-
.2010
Mandatory notification of trade
Wenche Rolfsen, Chairman of the Board of Bionor Pharma ASA, has today acquired 65 000 shares in the Company
-
.2010
New name and new ticker from Monday 14.06.2010
Nutri Pharma ASA changes the company's name to Bionor Pharma ASA.
-
.2010
Nutri Pharma ASA to change name to Bionor Pharma ASA
On 19 May 2010 Nutri Pharma ASA's Annual General Meeting resolved to change the company name from Nutri Pharma ASA to Bionor Pharma ASA.
-
.2010
NutriPharma ASA and subsidiary Bionor Immuno AS Change Name to Bionor Pharma ASA; New Board Selected by Shareholders at Annual General Meeting
27.05.2010 - Norwegian Nutri Pharma ASA (OSLO: NUT) and its subsidiary Bionor Immuno AS today announced that the parent Company Nutri Pharma ASA will now be known as Bionor Pharma ASA
-
.2010
First Quarter Results 2010 Nutri Pharma ASA
19.05.2010 - Please find attached financial statement for the 1st quarter of 2010.
-
.2010
Minutes from the Annual General Meeting of Nutri Pharma ASA
19.05.2010 - Nutri Pharma ASA´s Annual General Meeting was held today, 19 May 2010. All proposed resolutions in the notice to the meeting were approved by the shareholders
-
.2010
The proposal of the Nomination Committee and amendment to item 11 of the Norwegian AGM summons
14.05.2010 - The Nomination Committee proposes that the following candidates be elected to the Board of Directors of Nutri Pharma ASA
-
.2010
Ny CFO i Nutri Pharma ASA
06.05.2010 - Rolf Henning Lem er ansatt som ny CFO i Nutri Pharma ASA. Rolf Henning skal, i tillegg til de funksjoner som ligger under CFO-stillingen, bistå aktivt i arbeidet med å kommersialisere Bionor Immunos teknologiske plattform mot farmasiselskaper internasjonalt
-
.2010
Annual accounts 2009 approved by the Board of Directors
28.04.2010 - The Board of Directors of Nutri Pharma ASA has today approved the Annual Accounts for 2009
-
.2010
Invitation to the Annual General Meeting
28.04.2010 - The Annual General Meeting of Nutri Pharma ASA will be held on Wednesday 19 May 2010, 10:00 a.m. at the company's offices at Kronprinsesse Märthas plass 1
-
.2010
Minutes from the EGM
28.04.2010 - The Extraordinary General Meeting of Nutri Pharma ASA has today resolved to elect Mr. Eric Cameron as Chairman of the Board of Directors
-
.2010
Extraordinary shareholders meeting
07.04.2010 - Nutri Pharma ASA has today sent the attached notice to shareholders of the company
-
.2010
Changed Financial Calendar 2010
06.04.2010 - Reference is made to the notification from the company of 6 April 2010. Due to changes in the Board of Directory of Nutri Pharma ASA there is need for anExtraordinary General Meeting the 28th of April
-
.2010
Innkalling til Ekstraordinær Generalforsamling
05.04.2010 - Det innkalles herved til ekstraordinær generalforsamling i Nutri Pharma ASA den 28.april 2010 klokken 10.00 på selskapets forretningskontor i Kronprinsesse Märtas Plass 1 i Osl
-
.2010
Mandatory notification of trade - Nutri Pharma ASA
05.04.2010 - Reference is made to the primary insider notification of 18 February 2010 regarding Lars Høie and notification from the company of 6 April 2010. Lars Høie is a member of the Board of Directors of Nutri Pharma ASA
-
.2010
CHANGES TO THE BOARD OF DIRECTORS OF NUTRI PHARMA ASA
05.04.2010 - Thorleif Krarup, chairman of the board of directors of Nutri Pharma ASA (ticker "NUT") has informed that he wishes to resign from his position as chairman of the board
-
.2010
Subsequent Offering
17.03.2010 - Reference is made to stock exchange notice dated 8 March 2010, the prospectus dated 18 February 2010 regarding the subsequent offering of up to 10,000,000 Subsequent Offering Shares in Nutri Pharma ASA ("Nutri Pharma") to a price of NOK 2.00 per share
-
.2010
Completion of Subsequent Offering
08.03.2010 - Reference is made to the prospectus dated 18 February 2010 regarding the subsequent offering of up to 10,000,000 Subsequent Offering Shares in Nutri Pharma ASA ("Nutri Pharma") to a price of NOK 2.00 per share, constituting gross proceeds of up to NOK 20,000,000 (the "Subsequent Offering")
-
.2010
Changed Financial Calendar 2010
05.03.2010 - Due to changed plan for Board Meetings in Nutri Pharma ASA the release of Q2 for 2010 is postponed from 26(th) of August, to 31(st) of August 2010
-
.2010
Approved supplemental prospectus
26.02.2010 - Oslo Børs has approved following supplemental prospectus:NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA
-
.2010
CORRECTION: FOURTH QUARTER AND PRELIMINARY 2009 RESULTS
23.02.2010 - This is a correction of the announcement from 19:02 23.02.2010 CET. Reason for the correction: The attached file appeared in zip-format for some receipients. Please see the Q4 report in a pdf-format instead
-
.2010
FOURTH QUARTER AND PRELIMINARY 2009 RESULTS
23.02.2010 - Turnover from sale to Nikken was for FY 2009 MNOK 14.1. Nikken topped up its inventories in conjunction with the launch in May 2009
-
.2010
Mandatory notification of trade
22.01.2010 - KAG AS a company fully owned and controlled by Birger Sørensen CEO of Bionor Immuno AS (a subsidiary of Nutri Pharma ASA), has has today purchased 90.000 NUTshares at NOK 2.10 per share
-
.2010
New Primary insiders in NUT 19 February 2010
19.02.2010 - Reference is made to the stock exchange notification published by 18 February 2010 regarding primary insiders in Nutri Pharma ASA ("NUT")
-
.2010
Approved prospectus
19.02.2010 - NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA. Please visit this link to access the prospectus
-
.2010
Commencement of subscription period for subsequent offering
19.02.2010 - Reference is made to stock exchange notice 18 February 2010 regarding completion of private placement in Nutri Pharma ASA ("NUT" or the "Company") of 50 million shares (the "Private Placement") as well as previous stock exchange notices
-
.2010
Approved prospectus
18.02.2010 - Offering and listing of up to 10,000,000 Subsequent Offering Shares each with a nominal value of NOK 0.25 in connection with a repair offering to Eligible Shareholders at a subscription price of NOK 2.00 raising total gross proceeds of up to NOK 20,000,000
-
.2010
Share capital increase and registrations in the Norwegian Register of Business Enterprises
18.02.2010 - Reference is made to the stock exchange notice of 12 February 2010 regarding the extraordinary general meeting of Nutri Pharma ASA (the "Company")
-
.2010
Notice of EGM resolutions
12.02.2010 - At the Extraordinary General Meeting (EGM) of Nutri Pharma ASA held in Oslo on Friday February 12, 2010, all of the resolutions proposed by the Board were dulypassed
-
.2010
Nutri Pharma announces candidates proposed for election to the Board of Directors at the EGM 12 February, 2010
09.02.2010 - The proposed new Board of Directors will have complementary experience within business, law, and medicine suited to undertake the tasks
-
.2010
TRANSACTION RELATING TO THE VOLUNTARY OFFER OF ALL THE SHARES IN BIONOR IMMUNO AS
05.02.2010 - On 14 January 2010, Nutri Pharma ASA ("NUT" or " Nutri Pharma") submitted a voluntary offer to purchase all of the shares and warrants in Bionor Immuno AS ("BI" or "Bionor Immuno")
-
.2010
Ex-date in Subsequent offering in Nutri Pharma ASA
01.02.2010 - Reference is made to the stock exchange release dated today regarding Nutri Pharma ASA ("the Company") successfully raising NOK 100 million in a contemplated Private Placement
-
.2010
Nutri Pharma ASA successfully raising NOK 100 million
01.02.2010 - Reference is made to the stock exchange release dated Monday 25 January 2010 regarding the contemplated Private Placement of new shares in Nutri Pharma ASA
-
.2010
Thorleif Krarup proposed as new Chairman of Nutri Pharma ASA
25.01.2010 - Thorleif Krarup to be proposed as new Chairman of the Board in Extraordinary Shareholders Meeting to be held on February 12
-
.2010
Private Placement
23.01.2010 - Nutri Pharma ASA refers to stock exchange release dated 21 January regarding contemplated private placement as a condition for the completion of the offer toshareholders in Bionor
-
.2010
Financial calender 2010
23.01.2010 - Financial calender 2010
-
.2010
Extraordinary shareholders meeting
22.01.2010 - Notice for extraordinary shareholders meeting Nutri Pharma has today sent the attached notice to shareholders of the company
-
.2010
Status Offer for shares in Bionor Immuno; contemplated private placement
21.01.2010 - With reference to the release 20 January and the release 12 January and theoffer document for offer to shareholders in Bionor Immuno AS (the "Offer"), Nutri Pharma ASA ("Nutri Pharma" or the "Company")
-
.2010
Offer for shares in Bionor Immuno AS
20.01.2010 - With reference to the release 12 January and the offer document for offer to shareholders in Bionor Immuno, Nutri Pharma announces that it has receivedacceptances for 96,54% of the shares in Bionor Immuno
-
.2010
Mandatory notification of trade
18.01.2010 - Board member Lars H. Høie has today purchased 2.000.000 NUT shares at NOK 2.81 per share
-
.2010
Voluntary offer from Nutri Pharma ASA to purchase shares in Bionor Immuno AS
14.01.2010 - Nutri Pharma ASA ("Nutri Pharma") hereby presents the voluntary offer to purchase shares in Bionor Immuno AS ("Bionor")
-
.2010
Nutri Pharma ASA to launch a voluntary offer for vaccine developer Bionor Immuno AS
12.01.2010 - Nutri Pharma ASA ("Nutri Pharma") to submit a voluntary exchange offer ("Offer") for all outstanding shares in Bionor Immuno AS("Bionor"). The shareholders of Bionor will be offered 1 Nutri Pharma share per 2 shares in Bionor...